Unconventional Pathway of Ubiquitination by Legionella Pneumophila Identified in New Research

Strategic Insights -

Legionella pneumophila, the pathogen responsible for Legionnaires' disease, has been found to use a divergent pathway to ubiquitinate host proteins, crucial for its proliferation. This process is orchestrated by effector proteins from the SidE family, which initially use NAD to ADP-ribosylate ubiquitin. The subsequent step relies on SidE phosphodiesterase activity to conjugate phosphoribosyl-Ubiquitin to serine residues in host substrates. A new study has identified a potent inhibitor, cephalosporin C Zn salt, which shows an IC of 221 nM, highlighting the potential for disrupting these crucial steps in bacterial infection.

Key Takeaways:

  • The Legionella pneumophila pathogen uses an unconventional pathway to ubiquitinate host proteins, which is crucial for its proliferation.
  • The process is orchestrated by effector proteins from the SidE family, which initially use NAD to ADP-ribosylate ubiquitin.
  • A fluorogenic assay was used to identify small molecule modulators of the SdeA effector enzyme, resulting in the discovery of a potent inhibitor called cephalosporin C Zn salt.
  • The inhibitory properties of cephalosporin analogs were measured and compared, with findings suggesting that the inhibition is primarily attributed to the presence of the Zn ion.
  • The study concluded that the zinc ion causes the best inhibition of the Legionella effector.

Statistics:

  • Over 600 compounds were screened in the High-Throughput Screening format.
  • The IC of the potent inhibitor cephalosporin C Zn salt is 221 nM.
  • The study used a fluorogenic assay to identify small molecule modulators of the SdeA effector enzyme.

Sources:

NewsRx. New Legionnaires' Disease Findings from Leiden University Medical Center Described (Development and Validation of a High-Throughput Screening Assay for the Legionella ADP-Ribosyl Transferase SdeA). TB & Outbreaks Week. October 14, 2025; p 3552.

ChemBioChem. Development and Validation of a High-Throughput Screening Assay for the Legionella ADP-Ribosyl Transferase SdeA. 2025. Contact Wiley-v C H Verlag Gmbh, Postfach 101161, 69451 Weinheim, Germany. (Wiley-Blackwell - www.wiley.com/; ChemBioChem - onlinelibrary.wiley.com/journal/10.1002/(ISSN)1439-7633)